Cyclacel Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Cyclacel Pharmaceuticals, Inc.

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK…

Biotechnology
US, Berkeley Heights [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Cyclacel Pharmaceuticals, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Cyclacel Pharmaceuticals, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Cyclacel Pharmaceuticals, Inc..

End of CYCC's Analysis
CIK: 1130166 CUSIP: 23254L603 ISIN: US23254L8019 LEI: - UEI: -
Secondary Listings
CYCC has no secondary listings inside our databases.